Vest Financial LLC Has $1.20 Million Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Vest Financial LLC boosted its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 27.6% in the third quarter, according to its most recent filing with the SEC. The firm owned 133,338 shares of the pharmacy operator’s stock after acquiring an additional 28,814 shares during the period. Vest Financial LLC’s holdings in Walgreens Boots Alliance were worth $1,195,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. New Covenant Trust Company N.A. acquired a new position in shares of Walgreens Boots Alliance in the 1st quarter valued at $35,000. Iron Horse Wealth Management LLC increased its holdings in shares of Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 1,300 shares in the last quarter. FinTrust Capital Advisors LLC raised its position in shares of Walgreens Boots Alliance by 60.4% during the first quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock worth $46,000 after purchasing an additional 802 shares during the period. Blue Trust Inc. grew its position in shares of Walgreens Boots Alliance by 87.0% in the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 1,081 shares during the period. Finally, Continuum Advisory LLC increased its stake in Walgreens Boots Alliance by 71.2% during the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 1,020 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $10.45 on Tuesday. The company has a market cap of $9.02 billion, a price-to-earnings ratio of -1.55, a PEG ratio of 1.37 and a beta of 0.70. The company has a current ratio of 0.68, a quick ratio of 0.31 and a debt-to-equity ratio of 0.67. The company’s fifty day simple moving average is $9.41 and its 200 day simple moving average is $13.00. Walgreens Boots Alliance, Inc. has a 1-year low of $8.22 and a 1-year high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same period in the previous year, the business earned $0.67 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% compared to the same quarter last year. On average, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.57 earnings per share for the current fiscal year.

Analyst Ratings Changes

WBA has been the topic of a number of research reports. Barclays lifted their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. JPMorgan Chase & Co. lowered their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. Royal Bank of Canada cut their price target on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a report on Tuesday, July 2nd. Evercore ISI increased their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday, October 16th. Finally, UBS Group boosted their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average target price of $13.38.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.